Phase II trial of eribulin mesylate in recurrent or metastatic salivary gland malignancies

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0347|40|3|584-589

ISSN: 1043-3074

Source: HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol.40, Iss.3, 2018-03, pp. : 584-589

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract